Response

Journal of the National Cancer Institute

Volumn 102, Issue 5, 2010, Pages 359-360

  De Kok, Inge M C M ^a   Van Ballegooijen, Marjolein ^a   Habbema, J Dik F ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

AGE DISTRIBUTION; COST EFFECTIVENESS ANALYSIS; DRUG COST; HUMAN; LETTER; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; UTERINE CERVIX CANCER;

EID: 77749279752     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp524     Document Type: Letter

References (2)

1. Coupé VMH, Meijer CJLM, Berkhof J. Re: cost-effectiveness analysis of human papillo-mavirus vaccination in the netherlands [published online ahead of print october 27, 2009]. J Natl Cancer Inst. 2010:102(5):358.
2. de Kok IMCM, van Ballegooijen M, Habbema JDF. Response [published online ahead of print october 27, 2009]. J Natl Cancer Inst. 2010:102(5):358.